Chiu, Yun-Hsuan
Liang, Ya-Han
Hwang, Jeng-Jong
Wang, Hwai-Shi
Funding for this research was provided by:
National Science and Technology Council, Taiwan (MOST 107-2320-B-010-029-MY3)
Article History
Received: 7 March 2023
Accepted: 12 September 2023
First Online: 15 September 2023
Competing interests
: H.-S. Wang and J.-J. Hwang declare that a patent entitled “Composition and Use of Interleukin Stimulated Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Rheumatoid Arthritis” granted in Taiwan on 26-July-2022 (no. I 782355) is based on the research in this paper. An US patent application of the same title was filed on 8-JUN-2021. National Yang Ming Chiao Tung University holds awarded and pending patents. All other authors declare they have no competing interests.